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Abstract
Background: Malignant arthritis is a rare manifestation of metastatic disease. We describe the
case of a previously well 28 year old man in whom hip pain was the presenting symptom of disease.
We describe the case and discuss the aetiology of colorectal cancer in young patients. We then
review the literature and discuss the investigation and management of malignant joint arthritis.
Case presentation: We present the case of a 28 year old man who presented to the emergency
department with an acute monoarthritis of the hip. He had an unremarkable past medical history
and was systemically well. A diagnosis of malignant joint effusion was reached after a heightened
index of clinical suspicion, magnetic resonance imaging and cytological evaluation of the synovial
fluid. Computed tomography and bone scan confirmed widespread metastatic disease from a
primary colonic adenocarcinoma. The patient tolerated three cycles of oxaliplatin and capecitabine
but died 4 months after presentation.
Conclusion: The metastatic spread of cancer to the joint and the synovium is one of the rarest
manifestations of malignant disease and has not been previously reported as the presenting
symptom of disease. The diagnosis is a difficult one to reach and is associated with a poor prognosis.
This case illustrates the importance of thorough investigation in reaching this diagnosis and
entertaining the possibility in individuals who do not respond to conventional management of acute
monoarthritis, even in young patients and individuals who do not display any other symptoms of
disease.
Background
Colorectal cancer usually presents in patients in their 6th
to 8th decade or in individuals in whom there is a genetic
predisposition to develop cancer. The usual presenting
symptoms are commonly those of altered bowel habit,
abdominal pain, bleeding per anum, general malaise or a
microcytic anaemia of unexplained aetiology.
We present the unusual case of a young patient with no
apparent risk factors or genetic predisposition for colorec-
tal cancer who presented with an acute monoarthritis of
the hip as the first symptom of his disease.
Case presentation
A 28 year old male student of Nepalese origin living in the
United Kingdom for 3 years presented to the Accident and
Emergency department with a 3 week history of increasing
right hip pain, with associated fevers but no other symp-
toms and no history of trauma. 5 years previously, he had
been treated for pulmonary tuberculosis with a 6 month
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course of chemotherapy. There was no positive family his-
tory. The remaining history was unremarkable.
On admission he was partially weight bearing on the
affected side. On inspection there were no signs of inflam-
mation. Flexion was limited to100 degrees; extension to
20 degrees; internal and external rotation were reduced to
10 degrees with normal adduction and abduction. There
were no further positive findings on the remainder of
physical examination or X-ray (figure 1).
Blood results on admission were haemoglobin 12.5 g/dl
(12.5–18.0 g/dl), white cell count 6.47 (4.0–11.0 × 109/l),
Platelets 378 (150–400 × 109/l), C reactive protein (CRP)
205 (<5 mg/l), Erythrocyte sedimentation rate (ESR) 96
(2–12 mm/1st hour). His biochemistry revealed an alka-
line phosphatase (ALP) 342 (30–300 iu/L), bilirubin 15
(3–17 μmol/L), alanine aminotransferase (ALT) 45 (3–35
iu/L), aspartate transaminase (AST) 42 (3–35 iu/L), cor-
rected calcium 2.82 (2.12–2.65 mmol/L), lactate dehy-
drogenase (LDH) 782 (iu/L). Renal function was normal.
An Ultrasound of the hip revealed a moderate right sided
joint effusion. Magnetic resonance imaging (MRI) of the
pelvis and hips (figure 2) confirmed the effusion with
marked soft tissue swelling and synovial thickening. There
was oedema in the proximal femur.
Our working diagnosis was septic arthritis, with tubercu-
losis of the hip as a differential, in view of his past medical
history. He was thus managed accordingly with a washout
and commenced on chemotherapy. Microbiology of the
synovial fluid revealed no organisms; auramine tests were
repeatedly negative, as was syphilis serology, Human
Immunodeficiency Virus (HIV), Hepatitis and melioido-
sis.
X-ray of the pelvis showing no positive findings Figure 1
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There was little clinical response to treatment and inflam-
matory markers 2 weeks after admission were elevated at
a CRP of 130 and ESR of 114.
He then developed an episode of diarrhoea and vomiting
as an inpatient. Initial investigations for amoeba, cysts,
ova, parasites were all negative. Colonoscopy was under-
taken and revealed a stricture in the sigmoid colon. Multi-
ple biopsies revealed a moderately to poorly differentiated
adenocarcinoma on histological examination. An immu-
nohistochemical panel showed the tissue to be cytokera-
tin 20 (CK-20) positive, cytokeratin 7 (CK-7) negative and
villin negative, thus in keeping with a colorectal primary
tumour. Carcinoembryonic antigen (CEA) was measured
at 100.7. Genetic screening and microsatellite instability
(MSI) testing on the tumour were negative.
The synovial fluid was re-examined for cytology following
the histological diagnosis and this confirmed a malignant
joint effusion.
A computerised tomogram (CT) revealed multiple para-
aortic lymph nodes, with no evidence of metastases other
solid organs. A bone scan (figure 3) revealed high uptake
areas in the skull vault, spine, ribs, pelvis, proximal ends
of both femurs and sternum; all in keeping with wide-
spread metastatic disease.
In view of the advanced nature of the adenocarcinoma the
primary tumour was not resected and he was commenced
on Oxaliplatin 130 mg/m2 (day one of cycle) and Capecit-
abine 1.25 g/m2 (twice daily for fourteen days) for a
planned eight cycles (each cycle of twenty-one days). He
MRI of the pelvis showing effusion with soft tissue swelling and synovial thickening Figure 2
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Bone Scan showing high uptake in skull vault, spine, ribs, pelvis, both femur and sternum suggestive of widespread metastatic  disease Figure 3
Bone Scan showing high uptake in skull vault, spine, ribs, pelvis, both femur and sternum suggestive of widespread metastatic 
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responded well initially with an improvement sympto-
matically after 2 cycles of chemotherapy, and objectively
on computerised tomogram (CT) of his abdomen and
pelvis with reduction in the size and number of significant
lymph nodes. However was unable to tolerate more than
3 cycles and died 4 months after his initial presentation.
Discussion
Adenocarcinoma of the colon in young patients is rare
with only 2% of diagnosed colonic cancers in patients 40
years or younger [1]. Risk factors include inflammatory
bowel disease and low fibre diet but the majority in this
age group are hereditary being attributable to two recog-
nised syndromes.
The first is familial adenomatous polyposis (FAP); the
underlying cause is a gene mutation adenomatous poly-
posis coli (APC) gene on chromosome 5. This usually has
a clear phenotype, characterised by numerous adenoma-
tous polyps in the large bowel by the third decade of life
and invariably develop into cancers.
The second is hereditary non-polyposis colorectal cancer
(HNPCC) syndrome. Here the colorectal cancer also
arises from adenomas, but the degree of polyposis is less
marked than in FAP. This syndrome has a heterogeneous
spectrum, and the phenotype is more difficult to define
than in FAP [2]. It is now known to be caused by muta-
tions in mismatch repair genes, with different distinct
gene mutation patterns explaining the variability in phe-
notype [3]. Such errors are particularly prominent in mic-
rosatellites where the DNA sequence is repetitive and are
said to demonstrate instability. It is this area that there is
much interest currently to account for young patients pre-
senting with cancers of the colon.
Regular screening of young individuals for colorectal can-
cer with positive risk factors with regular colonoscopy and
genetic testing for FAP and HNPCC (testing for microsat-
ellite instability)[4] is of great importance and this
accounts for the majority of young patients presenting
with colorectal carcinoma. In this case, whilst genetic
screening proved to be negative, a genetic basis for color-
ectal carcinoma is still the most likely, but this would
probably represent a new mutation.
Patients who develop metastatic arthritis secondary to
solid tumours are rare. It is even more uncommon for this
to be a presenting symptom.
A review of the English language literature reveals that
there have been 22 reported cases of malignant joint effu-
sion associated with solid organ malignancy [5-7].
Although there are a number of malignancies which clas-
sically spread to bone, over half of the reported cases with
metastatic carcinomatous arthritis were associated with
lung cancer. The most commonly affected joint is the knee
and symptoms usually present in the joint some time after
the diagnosis of the primary cancer has been made.
There have only been three cases reported associated with
colon cancer [6-8] and the average age of these patients
was 72 years (the individual ages were 62, 73 and 83).
The mechanism by which the primary cancer metastasizes
to the synovium has been hypothesised to occur by one of
two mechanisms. The first is direct haematogenous spread
to the synovium [8]. The second that the carcinoma first
metastasizes to the bone and then further spreads to the
synovium [9] – this theory would be supported by the
bone scan results in our case.
With a high index of clinical suspicion a diagnosis should
be sought by examination of the synovial fluid [10], how-
ever this is only positive in approximately 50% of
cases[12]. If negative, a synovial biopsy is indicated, this
reaches a diagnosis in the majority of patients. In 7
reported cases both investigations were negative and a
positive diagnosis was only reached at autopsy [11].
Treatment is aimed at symptomatic relief. Radiation ther-
apy has been shown to provide some temporary relief
[12], with analgesics being the main form of treatment.
Patients with articular metastasis have a worse prognosis,
with an average survival of less than 5 months from the
time of diagnosis [13].
Conclusion
The metastatic spread of cancer to the joint and the syn-
ovium is one of the rarest manifestations of malignant
disease and has not been previously reported as the pre-
senting symptom of disease. The diagnosis is a difficult
one to reach and is associated with a poor prognosis. This
case illustrates the importance of thorough investigation
in reaching this diagnosis and entertaining the possibility
in individuals who do not respond to conventional man-
agement of acute monoarthritis, even in young patients
and individuals who do not display any other symptoms
of disease.
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